Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 1, Pages e000544
Publisher
BMJ
Online
2020-04-29
DOI
10.1136/jitc-2020-000544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
- (2019) Marit M. Melssen et al. Journal for ImmunoTherapy of Cancer
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis
- (2016) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway
- (2016) Nicolas Riteau et al. JOURNAL OF IMMUNOLOGY
- A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans
- (2015) Olga Pleguezuelos et al. Clinical and Vaccine Immunology
- Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
- (2014) Jacob Atsmon et al. VACCINE
- Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
- (2014) Audry Fernández et al. Human Vaccines & Immunotherapeutics
- Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide
- (2013) Elise P. Salerno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
- (2013) Christopher B Fox et al. Expert Review of Vaccines
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Data, information, knowledge and principle: back to metabolism in KEGG
- (2013) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine
- (2012) Jacob Atsmon et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial
- (2012) Olga Pleguezuelos et al. VACCINE
- 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
- (2012) Jane L. Messina et al. Scientific Reports
- Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
- (2011) Craig L. Slingluff et al. JOURNAL OF CLINICAL ONCOLOGY
- The Vaccine-site Microenvironment Induced by Injection of Incomplete Freundʼs Adjuvant, With or Without Melanoma Peptides
- (2011) Rebecca C. Harris et al. JOURNAL OF IMMUNOTHERAPY
- Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis
- (2010) Jochen T Schaefer et al. Journal of Translational Medicine
- Unmet needs in modern vaccinology
- (2010) Geert Leroux-Roels VACCINE
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- GAGE: generally applicable gene set enrichment for pathway analysis
- (2009) Weijun Luo et al. BMC BIOINFORMATICS
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
- (2009) Erica L Carpenter et al. Journal of Translational Medicine
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started